 | |||||||||
Regina, SK – TheNewswire - March 15, 2024 – PureJet Inc. (“PureJet”) a division of Atlantis Research Labs (“Atlantis Labs”) an aerospace technology company entered into a binding memorandum of understanding (MOU) with EmissionTech RX Corp (“EmissionTech RX”) for the sale of its methane incineration products and related intellectual property. The MOU brings PureJet’s proprietary emissions reduction technology alongside Carbon RX Inc (“Carbon RX”) providing a pipeline of carbon crediting services needs where the PureJet incinerator is deployed.
“We are excited to add the family of PureJet incinerators to our group of companies,” says Marty Seymour, CEO of EmissionTech RX. “Acquiring this technology gives EmissionTech RX methane destruction capability in a variety of applications. Carbon RX will benefit through the validation and verification and streaming of the carbon credits produced.”
PureJet’s proprietary methane destruction technology is the result of advanced aerospace technology developed by Atlantis Labs over the previous 10 years that was customized to treat waste gas created as a result of oil and gas extraction. The key to its innovative application is the absence of moving parts.
“PureJet technology emerged from our jet propulsion work in the aerospace sector and has evolved into one of the worlds most premier waste gas treatment solution”, says Vladimir Mravcak, CEO of Atlantis Research Labs, developer of PureJet Technology. “We are excited to deliver a world-class solution to treat methane at any pressure, particularly as methane is 28x more harmful to the atmosphere than CO2.”
According to the International Energy Agency (IEA), in 2022 the global energy sector is responsible for nearly 135 million tonnes of methane emissions; the equivalent of 945 Million cars on the road. The IEA notes 75% of these methane emissions can be reduced by implementing mitigation practices.
The binding MOU was part of a signing ceremony held in Regina on Friday, February 18th, 2024.
Featured L-R: Director Atlantis Research Labs, Garth Frederickson, CEO of EmissionTech RX, Marty Seymour, Founder of PureJet, Vladimir Mravcak
About EmissionTech RX Inc.
EmissionTech RX located in Regina, SK is committed to reducing methane emissions from oil, gas, and animal agriculture as well as offering carbon credit project development through its affiliation with Carbon RX in the agriculture, forestry, and hydrocarbon sectors.
About Carbon RX
Headquartered in Treaty 4 Territory in Regina, SK, Carbon RX specializes in the origination and streaming of carbon credits on First Nation land. Backed by a team of agriculture, forestry, and hydrocarbon experts, Carbon RX provides high-fidelity carbon credits to the voluntary carbon market, ultimately aiding global companies in the race to net zero emissions.
About PureJet Inc.
Headquartered in Calgary, AB, PureJet Inc. was established in 2015 with a commitment to enhancing environmental sustainability in the global energy sector. PureJet Inc. leverages technology innovations to improve methane gas management. The company contributes to a cleaner future through the deployment of PureJet® waste gas incinerators, focused primarily in the upstream oil and gas sector.
About Atlantis Research Labs Inc.
Atlantis Research Labs, established in 2007, is a Canadian research and development company at the forefront of innovation. Atlantis Research Labs is the inventor of advanced waste gas incineration technology with up to 99.9% methane combustion efficiency. Atlantis has helped evolve the current state-of-the-art in combustion and propulsion technologies for the aerospace, energy, and defence sectors. Atlantis serves these markets through advanced capabilities in engineering, manufacturing, and patent licensing.
For more information, visit carbonrx.com.
For media inquiries
Carson Sinclair
Cell: 306-690-9235
E‐mail: carson.sinclair@carbonrx.com
Forward-Looking Statements
This news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation, which is based upon Delta CleanTech Inc. (“Delta”) , Carbon RX (Delta’s subsidiary), and EmissionTech RX Corp’s current internal expectations, estimates, projections, assumptions and beliefs and views of future events. All statements other than statements of historical fact are forward-looking information. Forward-looking information can be identified by the use of forward-looking terminology such as "expect", "likely", "may", "might", "will", "shall", "should", "intend", "anticipate", "project", "contemplate", "continue", "potential", "proposed", "estimate" and other similar words, including negative and grammatical variations thereof, or statements that certain events or conditions "may", "would" or "will" happen, or by discussions of strategy. Forward-looking information include estimates, plans, expectations, opinions, forecasts, projections, targets, guidance, or other statements that are not statements of fact. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. No assurance can be given that these expectations will prove to be correct and such forward-looking information included in this news release should not be unduly relied upon. These statements speak only as of the date of this news release. Carbon RX does not undertake any obligations to publicly update or revise any forward-looking information except as required by securities law. Specifically, this news release contains forward looking information related to the MOU between EmissionTech RX Crop and PureJet Inc and the purchase and sale of PureJet’s methane incinerations products and related intellectual property to EmmissionTech RX Corp.
The CSE does not accept responsibility for the adequacy or accuracy of this release.
Copyright (c) 2024 TheNewswire - All rights reserved.
